These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6298339)

  • 21. [Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia].
    Paktoris EA; Trofimova LI; Sergeeva NA; Sinaĭko GA; Shakhgil'dian IV
    Vopr Virusol; 1979; (2):156-61. PubMed ID: 107654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus infection and primary hepatocellular carcinoma.
    Tabor E; Gerety RJ; Vogel CL; Bayley AC; Anthony PP; Chan CH; Barker LF
    J Natl Cancer Inst; 1977 May; 58(5):1197-200. PubMed ID: 192895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-epidemiologic aspects of the HBs-antigen carrier state in children].
    Uchaĭkin VF; Khokhlova EN; Asratian AA; Provotorov VI; Buturlaeva ON
    Pediatriia; 1988; (11):28-32. PubMed ID: 3226800
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and immunological studies on viral hepatitis (author's transl)].
    Toyota J
    Hokkaido Igaku Zasshi; 1978 Sep; 53(5):287-302. PubMed ID: 311328
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies against e-antigen in patients with HBsAg-positive liver diseases].
    Thamer G; Gmelin K; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():557-8. PubMed ID: 612030
    [No Abstract]   [Full Text] [Related]  

  • 30. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled study of hepatitis core antibody (HBcAb) in primary hepatocellular carcinoma and liver cirrhosis in Kenya.
    Bowry TR; Shah MV; Ahmad Z
    East Afr Med J; 1981 Aug; 58(8):576-82. PubMed ID: 6271520
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
    Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
    Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 38. Seroconversion from HBs-Ag to anti-HBs in a case of liver cirrhosis associated with hepatocellular carcinoma.
    Unakami M; Komiya I; Endo Y; Hara M; Ikeda K; Kumada H; Yoshiba A; Hino O; Kitagawa T
    Tohoku J Exp Med; 1987 May; 152(1):81-6. PubMed ID: 3039691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of hepatitis B in a group of Vietnamese boat-refugees in the Netherlands.
    Bänffer JR
    Trop Geogr Med; 1982; 34(3):251-5. PubMed ID: 7179464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis B antigens (surface and e) and their antibodies in viral hepatitis patients, pregnant women and newborn infants in the Mongolian People's Republic].
    Vorozhbieva TE; Purévdavaa E; Farber NA; Shakhgil'dian IV; Olzvoĭ G
    Vopr Virusol; 1982; (1):53-7. PubMed ID: 7072229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.